AWE
NXTM

Avidian Wealth Enterprises’s NxStage Medical Inc. NXTM Stock Holding History

Avidian Wealth Enterprises’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-13,774
Closed -$344K – 103
2016
Q3 		$344K Buy
+13,774
New +$321K 0.14% 48

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Avidian Wealth Enterprises's NXTM Position: Q4 2016 in Review

Avidian Wealth Enterprises sold out of NxStage Medical Inc. (NXTM) in Q4 2016, closing a stake of 13,774 shares — an estimated $344K sold.

Avidian Wealth Enterprises first reported a position in NXTM in Q3 2016 and held it in 1 quarter. The position peaked at $344K in Q3 2016. 170 funds tracked by Wall St. Rank hold NXTM as of Q4 2016.

  • Avidian Wealth Enterprises reported no remaining NxStage Medical Inc. position as of Q4 2016 after selling out during the quarter.
  • Avidian Wealth Enterprises sold 13,774 NxStage Medical Inc. shares in Q4 2016, an estimated $344K.
  • Avidian Wealth Enterprises first reported a position in NxStage Medical Inc. in Q3 2016 and held it in 1 quarter.
  • Avidian Wealth Enterprises's NxStage Medical Inc. position peaked at $344K in Q3 2016.
  • 170 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2016.

Based on Avidian Wealth Enterprises's 13F filing for Q4 2016, filed 14 Feb 2017.